Signs and Symptoms of Hodgkin's Lymphoma

As one of two primary categories of lymphatic cancer, Hodgkin's lymphoma (HL) attacks the patient's white blood cells, called lymphocytes. Hodgkin's lymphoma typically progresses in an orderly fashion from one group of lymph nodes to another, while it's cousin, non-Hodgkin's lymphoma (NHL) describes a number of diseases with different spread rates and patterns.

Understanding how the signs and symptoms of Hodgkin's lymphoma differ from those of NHL can help identify the disease early, although only a qualified oncologist can make a definitive diagnosis.

Some of the external signs and symptoms of Hodgkin's lymphoma include:

  • Swollen or enlarged lymph nodes - The most common symptom, lymphadenopathy most frequently involves the nodes in the neck and shoulders. Nodes in the chest can also be involved, and are usually detected with a chest radiograph. Nodes are sometimes rubbery in feel and do not hurt when palpated.
  • Unexplained weight loss - Can sometimes cause the loss of ten percent or more of a patient's body weight.
  • Fever and chills - Known as a Pel-Ebstein fever, there is some debate whether this is a true symptom.
  • Night sweats
  • Itching
  • Loss of appetite
  • Back pain - Non-specific, but often localized to the lower back.

Night sweats, fever, and weight loss are called B symptoms and are indicative of systemic involvement.

In addition to these signs, there may be more indicative symptoms upon internal investigation by chest scan or other radiographic technique, including:

  • Swollen liver, spleen, or both - About 30 percent of patients display an enlargement of the spleen, but it is not typically significant, and may in fact change over the course of treatment. If the liver has become involved, it may present as swelling, as happens in about five percent of cases.
  • Lowered platelet count

An additional classical presentation symptom is pain following the consumption of alcohol. It only occurs in two to three percent of patients with HL, so is highly non-sensitive, but it is considered a highly specific sign, meaning that it alone is enough to provide a positive HL diagnosis. The pain is localized to a particular lymph node and appears within minutes of consuming alcohol. It can be a sharp, stabbing pain or a dull, aching one.

Many of the signs and symptoms of Hodgkin's lymphoma may not be cause for alarm on their own, but if you have or suspect you may have any of them, it's a good idea to see a doctor, who should be able to determine whether further action is necessary.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap